© Reuters. FILE PHOTO: A person walks past a Pfizer logo amid the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., April 1, 2021. REUTERS/Carlo Allegri/File Photo
LONDON (Reuters) – Pfizer (NYSE:) plans to exit its 32% stake in Haleon, its consumer health joint venture with GSK, after the business is spun off as an independent company in July, GSK said on Wednesday.
Pfizer has a 32% stake in Haleon, which produces Sensodyne toothpaste and Advil painkillers.
In a statement, GSK said Pfizer will exit its investment in a “disciplined manner”.
Be the first to comment